Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Ease - folllow-up to yesterday`s post
Reply New Message
Prev Message Back To Forum Threaded View Next Message

RE: Ease - folllow-up to yesterday`s post

posted on Apr 18, 2006 10:16AM
Bingo Kiddtrader! I have re-examined the Fujitsu pr`s and I believe the Fujitsu deal alone funds the entire second dividend, and it just may be that, in its entirety, our share is/will be for much more than $15 mm.

Also note this phrase ``This strategically significant licensing agreement with Fujitsu ....``. The words ``strategically significant`` jumped out to me.

Why is it ``strategically significant``? The answer(s) to that is/are intriguing, and all positive. I have my theories.

Best

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply